Baxion
Screening
Tags
Alerts
Theme
Relmada Therapeutics, Inc.
RLMD
·
NASDAQ
·
$7.17
Share Price as of 11/2
·
$526M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/19/26
10-Q
Q3 ended 09/30/25
11/13/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K
Current report
09/08/26
8-K
Current report
08/06/26
8-K
Current report
07/28/26
8-K
Current report
05/28/26
8-K
Current report
05/12/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
06/18/26
S-3ASR
Automatic shelf registration
05/13/26
424B3
Prospectus
04/09/26
S-3
Shelf registration
04/03/26
424B5
Prospectus supplement
01/30/26
Proxies
Filter
DEF 14A
Definitive proxy
04/17/26
DEFA14A
Additional proxy materials
04/17/26
PRE 14A
Preliminary proxy
04/06/26
DEF 14A
Definitive proxy
04/11/25
DEFA14A
Additional proxy materials
04/11/25
Ownership
Filter
Form 4
Insider transaction
09/11/26
Form 4
Insider transaction
09/11/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G
Beneficial ownership
07/29/26
SC 13G
Beneficial ownership
06/22/26
Other
Filter
EFFECT
Request for effectiveness
04/09/26
CORRESP
Correspondence with the SEC
04/07/26
UPLOAD
Letter from the SEC
04/07/26
EFFECT
Request for effectiveness
09/12/24
CORRESP
Correspondence with the SEC
09/11/24
Latest Filings
Filter
8-K
Current report
09/08/26
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Current report
08/06/26
8-K
Current report
07/28/26
S-8
Registration of securities for employees
06/18/26
Ownership
Filter
Form 4
Insider transaction
09/11/26
Form 4
Insider transaction
09/11/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G
Beneficial ownership
07/29/26
SC 13G
Beneficial ownership
06/22/26